MMedication Read More Should you take GLP-1 drugs for longevity?March 15, 2026 This is, indeed, part of a wider trend of mutual support at the fringes of pharmacology, with similar…
MMedication Read More Weight loss jab users warned they could be ‘worse off than before’March 5, 2026 Wegovy and Mounjaro are approved by the NHS for weight loss use (Image: OMaltseva via Getty Images) People…
MMedication Read More Weight returns four times faster after stopping weight-loss drugsJanuary 14, 2026 When people stop taking the new generation of weight-loss drugs, they pile back the kilos four times faster…
MMedication Read More Are Sexual Side Effects Emerging With GLP-1 Agonists?November 28, 2025 Few new drugs have sparked as much interest and as many questions as GLP-1 agonists. Originally developed to…
MMedication Read More Most GLP-1 Prescriptions Miss the Mark: Are Yours?July 30, 2025 GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic…
MMedication Read More GLP-1 RAs Protective Against Stroke, Neurodegeneration?July 22, 2025 TOPLINE: Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs), particularly semaglutide and tirzepatide, was associated with a…